Echopoint Medical is a fast-paced medical device start-up in London UK, a spin-out of the University College London. We develop, manufacture and commercialise cutting-edge cardiovascular devices with a bold vision to provide unprecedented sensing and imaging capabilities in minimally invasive procedures. Using breakthrough optical sensors and advanced algorithms, Echopoint Medical will significantly improve how patients with cardiovascular disease are treated, reducing cost and complications, and improving outcomes. The development team is composed of a small but diverse group of engineers, clinicians and management who strive to make a positive clinical impact.
Location: United Kingdom, England, London
Employees: 1-10
Total raised: $9.17M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Parkwalk A... | parkwalkad... |
| - | UCL Techno... | ucltf.co.u... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.02.2024 | Series A | $5.32M | - |
| 16.09.2019 | Seed | $3.85M | Parkwalk A... |
Mentions in press and media 7
| Date | Title | Description |
| 21.02.2024 | Echopoint Medical – raises £4.2m in series A funding round | Thrilled to announce our latest investment into Echopoint Medical as part of a £4.2m series A funding round. The University College London spin-out has designed an advanced diagnostic solution for cardiovascular care to improve patient outc... |
| 10.01.2024 | Ten Promising Medtech Startups Pitch at Precision Medicine Demo Day | The P4 Precision Medicine Accelerator, dedicated to supporting the UK’s leading precision medicine startups, recently hosted a demo day for the ten companies from its 2023 cohort to showcase their innovations to an audience of investors and... |
| 16.09.2019 | Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment | Coronary heart disease is a major cause of death worldwide and more than 7 million* people have a diagnosis in the UK alone. Narrowing arteries caused by the disease are commonly treated by the insertion of tiny tubes called stents, but the... |
| 16.09.2019 | London-based Echopoint raises €3.5 million to improve diagnoses and treatment courses for heart disease patients | Coronary heart disease is a major cause of death worldwide, and more than seven million people in the UK alone have a diagnosis. Narrowing arteries caused by the disease are commonly treated by the insertion of tiny tubes called stents – bu... |
| 16.09.2019 | Echopoint Medical Raises £2.8M in Funding | Echopoint Medical Ltd, a London, UK-based medtech company, raised £2.8M in funding. Backers included Parkwalk, the UCL Technology Fund and two grants from Innovate UK. The company intends to use the funds to to further develop the optical f... |
| - | Echopoint – closes investment round | Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment |
| - | Echopoint Medical | “Echopoint Medical - Addressing a Critical Gap in Diagnosis of ANOCA” |